Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POETIC: Perioperative Endocrine Therapy in Breast Cancer
NCT02338310Phase 3Active, not recruiting
- Sponsor
- The Institute of Cancer Research
- Start
- Sep 2008
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in breast cancer, sponsored by The Institute of Cancer Research. Primary endpoint: Time to recurrence at 5 years. Started Sep 2008; status: active, not recruiting.
02
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02338310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02338310.